The effect of case management on glycemic control in patients with type 2 diabetes

Case Manager

Volumn 14, Issue 6, 2003, Pages 43-47

  Middleton, Judi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

BLOOD ANALYSIS; CHRONIC DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DIET THERAPY; DISEASE COURSE; DYSLIPIDEMIA; FAMILY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIFESTYLE; MEDICAL RESEARCH; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; OBESITY; OUTCOMES RESEARCH; PATIENT CARE; RETINOPATHY; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 0242628321     PISSN: 10619259     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.casemgr.2003.09.007     Document Type: Article

References (5)

1. Drum D., Zierenberg T. The type 2 diabetes source book. 2000;Lowell House, Los Angeles.
2. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 24:(Suppl 1):2001;S33-S43.
3. Eli Lilly and Company. Controlling your blood sugar. 1997;Lilly, Indianapolis.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes in the development and progression of long term complications in insulin dependent diabetes. N Engl J Med. 329:1993;977-986.
5. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 352:1998;837-853.